Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitaflo Scandinavia is a specialized clinical nutrition company that provides medical foods for patients with rare inherited metabolic disorders, renal disease, and other conditions requiring highly specific diets. As a regional subsidiary of Vitaflo International and part of Nestlé Health Science, the company offers a comprehensive portfolio of amino acid-based formulas and specialized nutritional supplements. Their products are designed to manage conditions such as Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), and drug-resistant epilepsy through the ketogenic diet. Vitaflo is recognized for its focus on patient-centric innovation, developing palatable and convenient delivery formats that improve long-term dietary compliance. The company works closely with healthcare professionals across the Nordic region to support the complex nutritional needs of both pediatric and adult patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitaflo Scandinavia.